Fat-Derived stem cells injected into muscles in new myositis trial
NCT ID NCT04975841
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether stem cells taken from a person's own fat tissue are safe to inject into weakened muscles. Nine people with inclusion body myositis received injections in their forearm and thigh. The main goal was to check for side effects, not to measure improvement, though researchers hope this approach might eventually slow or reverse muscle weakness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- adipose-derived regenerative cells (stem cells from fat tissue)
- What this could lead to
- If safe and effective, this could point toward a treatment that slows or reverses muscle weakness in inclusion body myositis.
- What could go wrong
- This is a very early, small safety study with only 9 people. It is not designed to prove the treatment works, and larger trials are needed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INCLUSION BODY MYOSITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Wearable sensors could revolutionize monitoring of rare muscle disease
- Can diet help manage a rare muscle disease? new study seeks answers
- Shocking muscles to move: new exercise hope for nerve disease patients
- New study tracks rare muscle disease without offering treatment
- Patients take the lead: rare myositis study puts your voice first
- Could a transplant drug help patients with rare muscle disease?